I Wonder which race of people will be targeted to be the “TEST TUBED” ( I mean the test group for this new birth control? Hmmm! Read our Book “Test Tubed” and find out!
By Tom Olago
Medical technologies have advanced from simple birth control methods such as pills, to what is now being described as nothing short of a birth control revolution that could also revolutionize various other aspects of medicine: a microchip that could control a woman’s hormones, and prevent pregnancy for up to 16 years. According to reports, local researchers at Cambridge have developed the microchip that can be implanted under the skin and is accessible by remote control, delivering tiny amounts of hormone in much the same way as birth control pills.
According to cbsboston.com, this innovation was the result of a joint effort between M.I.T.(Massachusetts Institute of Technology) and bio-tech firm MicroCHIPS of Lexington; they first successfully tested the technology in 2012 in osteoporosis patients, attracting the support of the Bill and Melinda Gates Foundation which stepped in with a multi-million dollar grant to investigate whether the chip could be used to prevent pregnancy.
Some experts point out that women already have implantable birth control options like the IUD, but many still choose the pill. Given the prevalence and convenience of these long-used birth control systems, is there any real value that this new microchip process will bring, over and above the currently available and popular alternatives? Bob Farra, President and COO of MicroCHIPS says yes: unlike the IUD, the chip doesn’t need to be removed every time a woman is ready to have a child. When a woman wants to conceive, she or her doctor can turn off the device with a remote control.
Researchers are now concentrating on that remote, to make sure it can’t be hacked. As Farra asserts: “The remote control must be put up against the skin in order to establish communication…the reason we do that is we want people to have close range communication to prevent anyone from listening in to the encrypted signal.”
The plan is to have the device ready for testing on women in 2016. The estimated price tag will end up being around $1,000.
Other applications within various facets of medicine that have been beneficiaries of microchip implant-based medical technologies include osteoporosis, cardiovascular disease, multiple sclerosis, cancer, and chronic pain. Benefits based on clinical trials and studies being conducted since 2012 and reported in mchips.com are said to include:
• Reduction of the need for frequent injections: During clinical trials, patients received daily doses of the marketed osteoporosis drug Teriparatide through microchip delivery rather than daily injection.
- The drug released from the implanted microchip demonstrated similar measures of safety and therapeutic levels in blood to what is observed from standard, recommended multiple subcutaneous injections of Teriparatide.
- The device and drug combination were found to be biocompatible with no adverse immune reaction.
- The study also demonstrated that the programmable implant was able to deliver the drug at scheduled intervals. Drug delivery and evaluation in patients occurred over a one month period and provided proof-of-concept measures of drug release and device durability that support implantable device viability for 12 months or more.
- Patient surveys found that the microchip device was well-tolerated, and patients indicated that they would repeat the implant procedure.
- A microchip that continues to deliver Teriparatide with this or similar consistency and efficiency over 12 to 24 months could improve bone mass, density, architecture, and strength. This is according to co-author Robert Neer, Founder & Director of the Massachusetts General Hospital Bone Density Center and Associate Professor of Medicine at Harvard Medical School.
- The design of a next-generation microchip drug delivery device is the only approach to an implantable device that can be wirelessly programmed to release drugs inside the body without percutaneous (needle-puncture) connections in or on the patient.
- An implantable microchip device also provides real-time dose schedule tracking, and as part of a network, physicians can remotely adjust treatment schedules as necessary.
With such a wide array of actual and potential microchip features and benefits, little wonder that not much ado seems to have been raised around ensuring adequate controls and protocols against potential privacy and tracking violations within authorized establishments. As usual, it’s much easier to ignore the dangers when the benefits seem overwhelmingly popular and beneficial, and the public tnds to besold on the positive side, with the negativities masked somewhere in fine print.
This birth control system is eerily similar to what could potentially culminate in the mark of the beast system spoken of the Book of Revelations 13, where no-one will be able to buy or sell without a mark on their right hand or forehead. Such a mark would certainly require similar technologies as those currently supporting bio-chips and RFID tags today.
It is therefore no surprise that these current technologies are allowing age-old Biblical prophecies to unfold before our very eyes.